Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancer. [electronic resource]
Producer: 20160901Description: 769-73 p. digitalISSN:- 1532-3080
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Breast Neoplasms -- chemistry
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Lapatinib
- Lymphatic Metastasis
- Middle Aged
- Quinazolines -- administration & dosage
- Receptor, ErbB-2 -- analysis
- Survival Analysis
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vinorelbine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.